You are here: Home » Companies » News
Business Standard

Lupin eyes share of $48 mn market with anti-infection capsule launch in US

Lupin shares were trading 2.47% up at Rs 899.15 apiece on BSE on Friday

Press Trust of India  |  New Delhi 

Lupin

Drug on Friday said it has launched capsules, used to treat serious infections, in the American market.

The company has launched its in the strengths of 250 mg and 500 mg after having received approval from the (USFDA), said in a regulatory filing.

The Mumbai-based company's product is the generic version of Valeant Pharmaceuticals International Inc's Ancobon tablets.

The drug is indicated for the treatment of

According to the latest IMS sales data, capsules have annual sales of around $48 million in the US.

were trading 2.47 per cent up at Rs 899.15 apiece on on Friday.

First Published: Fri, January 05 2018. 17:08 IST
RECOMMENDED FOR YOU